Gliclazide: Enhancing Diabetes Management
🛒 How to order this item?
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Show More
Admira MR Tablet: Empowering Diabetes Control
Avoid consuming alcohol while taking Admira MR Tablet, as it could worsen your condition.
It is generally not advised to use Admira MR Tablet during pregnancy. Consult your doctor before taking it if you are pregnant.
Admira MR Tablet is generally not recommended for use in breastfeeding women. Consult your doctor before taking it if you are breastfeeding.
If you experience dizziness or blurred vision after taking Admira MR Tablet, avoid driving or operating machinery.
Admira MR Tablet is not recommended for use in patients with severe kidney disease. If you have decreased kidney function, use it with caution and consult your doctor.
Admira MR Tablet is not recommended for use in patients with severe liver disease. If you have decreased liver function, use it with caution and consult your doctor.
Admira MR Tablet works by increasing the release of insulin from your pancreas (a part of your digestive system that produces insulin and other vital enzymes). Thus it lowers your blood sugar levels.
Admira MR Tablet is used to treat maturity-onset diabetes, and diabetes with or without obesity in adults when diet, exercise, weight loss, or insulin therapy fail to provide adequate results.
Gliclazide, a second-generation sulfonylurea, holds hypoglycemic and potential hematological impacts. It curbs the liver's glucose production, concurrently spurring insulin secretion from pancreatic β-cells. This is achieved by enhancing Ca+2 transportation across the β-cell membranes.
Certain medications can interact with Gliclazide, affecting its hypoglycemic (blood sugar-lowering) effects:
Enhancing Hypoglycemic Effects:
Decreasing Hypoglycemic Effects:
Juvenile-Onset (Type-1) Diabetes: Gliclazide is not suitable for individuals with type-1 diabetes, which is characterized by the inability of the pancreas to produce insulin.
Diabetes Associated with Ketosis: Gliclazide is not recommended for diabetes patients experiencing ketosis, a condition where the body burns fat for energy due to insufficient insulin.
Diabetic Patients Undergoing Surgery, Severe Injury, or Infection: Gliclazide should be avoided in diabetic patients who are undergoing surgery, have experienced a severe injury, or are dealing with infections, as their medical conditions may affect the use of the medication.
Hypersensitivity to Sulfonylurea Group: If a patient has a known hypersensitivity or allergy to drugs in the sulfonylurea group, Gliclazide should not be used.
Pregnancy and Breastfeeding: Gliclazide is not recommended for pregnant or breastfeeding women due to potential risks to the fetus or infant.
Hepatic Insufficiency: Gliclazide should be avoided in patients with severe liver insufficiency.
Pregnant women should avoid using gliclazide. It should not be used by a woman who is breastfeeding.
Disclaimer:
ePharma sole intention is to ensure that its consumers get proper
information as musch as possible. Although we do not guarantee the
accuracy and the completeness of the information that provided and
here information is for informational purposes only.
The information contained herein should NOT be used as a substitute
for the advice of a qualified physician. This may not cover
everything about particular health conditions,
lab tests, medicines, all possible side effects, drug interactions,
warnings, alerts, etc. Please consult your healthcare professional
and discuss all your queries related to any disease or medicine. We
intend to support, not replace, the doctor-patient relationship.